Analyst
Bank of America
Equibles does not estimate personal net worth.
Neha is recorded as Analyst at Bank of America. Neha has spoken on 3 earnings calls across 2 companies, most recently for Mankind Pharma Limited on July 30, 2026. Those appearances were for Sun Pharmaceutical Industries Limited and Mankind Pharma Limited. The companies whose calls Neha spoke on are classified in the Healthcare sector.
“First, just an extension on the new product question. I think we'd mentioned last year that, you know, because of the change in EMR, et cetera, we weren't launching as many new products, which was one of the reasons for the lag.”
“Dick, a quick question on the U.S. speciality business. Would it be fair to assume that the, you know, growth that you are seeing in speciality in the U.S. so far, or let's say in FI26, is largely driven by Illumia?”
“My second question is on the INGRA business. Given the strong performance that we have seen and the upcoming launch of SEMA that you indicated, Should we expect this growth rate to improve further as we look, you know, look through the next quarter, particularly as we add SEMA?”
Bank of America
Analyst
Transcript header (unverified)
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Mankind Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Mankind Pharma Limited
Sun Pharma Q4 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
Sun Pharma Q3 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
